Perindopril/Indapamide

培哚普利/吲达帕胺

Report date: 2023/04/25 13:51:02

Base Information

Drug NamePerindopril/Indapamide
Drug Alias Name吲达帕胺/培哚普利Indapamide and Perindopril吲哒帕胺+培哚普利Perindopril and Indapamideindapamide and perindopril erbumine +[8] 
ClassificationSmall molecules
Mechanisms of ActionSymporters inhibitorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeSymporters
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryFrance
Original Approved Date1998/08/03
Country/TerritoryFranceJordanMainland China
CombinationsYes Perindopril ErbumineIndapamide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLes Laboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires ServierDarnitsa Pharmaceutical CoServier (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA04
Related LinksN/A